Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Prajakta P. Masurkar

ResearcherPublications, citations & collaboration network

Prajakta P. Masurkar is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 32 works, 119 citations, an h-index of 6 and an i10-index of 3.

32
Works
119
Citations
6
h-index
3
i10-index

How has Prajakta P. Masurkar's publication output changed over time?

ScholarIQpublication output · 2016–2025

Output grew0% over the shown period — from 1 works in 2016 to 1 in 2025.

1
1
2
1
1
3
1
2016202020212022202320242025

What are the most-cited papers on Prajakta P. Masurkar?

ScholarIQmost cited works
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA
Prajakta P. Masurkar, Haluk Damgacioglu, Ashish A. Deshmukh, Meghana V. Trivedi
PharmacoEconomics. 202326 Citations
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
S37256505. 202218 Citations
Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis
Prajakta P. Masurkar, Prachi Prajapati, Joanne Canedo, Swarnali Goswami, Sally Earl, Kaustuv Bhattacharya
Current Medical Research and Opinion. 202411 Citations
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu
S37256505. 20218 Citations
A naturalistic observation study of medication counseling practices at retail chain pharmacies
S. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit S. Sansgiry
Pharmacy Practice. 20207 CitationsOPEN ACCESS

Related on ScholarIQ

UCB Pharma (United States)
Institution
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA
Paper
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
Paper
Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis
Paper
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
Paper
A naturalistic observation study of medication counseling practices at retail chain pharmacies
Paper
470M+ articles · free account